Watchlist Price Alert

Eupraxia Pharmaceuticals Inc. (EPRX)

NASDAQ: EPRX · Real-Time Price · USD

3.79

-0.27 (-6.65%)

May 07, 2025, 3:57 PM - Market open

Eupraxia Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Net Income	-25.74M	-37.39M	-23.92M	-23.37M	-4.01M	-7.24M	-14.83M	-5M
Depreciation & Amortization	171.72K	209.91K	193.27K	111.53K	116.81K	201.94K	125.83K	85.38K
Stock-Based Compensation	3.22M	1.41M	1.43M	4.21M	228.68K	544.95K	2.92M	162.82K
Other Working Capital	-5.95M	6.47M	1.76M	-402.32K	832.37K	346.87K	1.31M	-259.17K
Other Non-Cash Items	-880.5K	1.53M	1.16M	3.41M	1.69M	869.41K	2.08M	51.17K
Deferred Income Tax	n/a	n/a	-305.15K	1.2M	10.91K	-28.86K	291.05K	n/a
Change in Working Capital	-6.76M	6.33M	2.07M	-211.43K	1.56M	482.14K	1.1M	-599.39K
Operating Cash Flow	-29.99M	-27.92M	-18.78M	-14.64M	-403.93K	-5.17M	-8.32M	-5.3M
Capital Expenditures	-104.23K	-73.38K	-308.37K	-431.67K	n/a	-9.48K	-141.86K	-314.69K
Cash Acquisitions	n/a	n/a	310.00	n/a	81.31K	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	-310	-9M	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	9.01M	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	29.07K	-1.81K	310.00	-5.02M	-56.69K	-1.89M	n/a	n/a
Investing Cash Flow	-75.16K	-99.03K	8.7M	-14.45M	24.62K	-1.9M	-141.86K	-314.69K
Debt Repayment	-9.14M	-144.44K	-97.49K	12.17M	-525.95K	5.66M	2.67M	463.06K
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	363.06K	12.1M	-87.7K	-87.7K	-100.69K	1.73M	2.62M	n/a
Financial Cash Flow	45.78M	27.84M	13.52M	49.92M	-626.64K	7.4M	5.3M	9.47M
Net Cash Flow	13.76M	1.08M	3.84M	20.74M	-1.01M	332.6K	-3.17M	3.85M
Free Cash Flow	-30.1M	-28.02M	-19.08M	-15.07M	-403.93K	-5.18M	-8.46M	-5.61M